logo

For the Inventor, By the Inventor

Branford, CT, United States of America

Lisa D Pfefferle

This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignee: Yale University. Active years: 2007-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lisa D Pfefferle. Retrieved from https://idiyas.com/inventor/lisa-d-pfefferle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 75.0

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:

goldMedal8 out of 1,371 
 
Yale University
 patents

Years Active: 2007-2019

Loading Chart...
8 patents (USPTO):Explore Patents
1. 10485856 - Carbon nanotube compositions and methods of use thereof (2019-11-26),
2. 9737593 - Carbon nanotube compositions and methods of use thereof (2017-08-22),
3. 8658178 - Carbon nanotube compositions and methods of use thereof (2014-02-25),
4. 7884450 - Growth of boron nanostructures with controlled diameter (2011-02-08),
5. 7531892 - Superconducting boron nanostructures (2009-05-12),
6. 7485279 - Growth of nanostructures with controlled diameter (2009-02-03),
7. 7357983 - Controlled growth of single-wall carbon nanotubes (2008-04-15),
8. 7258807 - Controlled growth of gallium nitride nanostructures (2007-08-21),

Title: Innovations of Lisa D Pfefferle

Introduction

Lisa D Pfefferle is a prominent inventor based in Branford, Connecticut. She has made significant contributions to the field of immunotherapy through her innovative work with carbon nanotube compositions. With a total of eight patents to her name, her research focuses on enhancing cellular immune responses.

Latest Patents

One of her latest patents involves carbon nanotube (CNT)-based compositions designed to activate cellular immune responses. These CNTs serve as high surface area scaffolds for the attachment of T cell ligands and/or antigens. The compositions function as artificial antigen-presenting cells (aAPCs) or modular vaccines. The disclosed CNT aAPCs are efficient at activating T cells and can be utilized to activate T cells ex vivo or in vivo for adoptive or active immunotherapy.

Career Highlights

Lisa D Pfefferle is affiliated with Yale University, where she continues her research and development in the field of immunotherapy. Her work has garnered attention for its potential applications in medical treatments and therapies.

Collaborations

Some of her notable coworkers include Gary L Haller and Dragos Ciuparu, who have collaborated with her on various research projects.

Conclusion

Lisa D Pfefferle's innovative work in carbon nanotube compositions has the potential to revolutionize immunotherapy. Her contributions to the field are significant and continue to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…